Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro

Brain Research
N NakaoT Itakura

Abstract

Recent in vitro studies have described the toxicity of levodopa (L-DOPA) to dopamine (DA) neurons. We investigated whether metabolic inhibition with rotenone, an inhibitor of complex I of the mitochondrial respiratory chain, may enhance the toxicity of L-DOPA toward DA neurons in mesencephalic cultures. The uptakes of DA and GABA were determined to evaluate the functional and morphological integrity of DA and non-DA neurons, respectively. Pretreatment with rotenone significantly augmented the toxic effect of L-DOPA on DA neurons. Interestingly, prior metabolic inhibition with rotenone rendered DA cells susceptible to a dose (5 microM) of L-DOPA that otherwise exhibited no toxic effect. DA uptake was more intensely attenuated than GABA uptake after the combined exposure to rotenone and L-DOPA. This was confirmed by cell survival estimation showing that tyrosine hydroxylase-positive DA cells are more vulnerable to the sequential exposure to the drugs than total cells. The selective toxic effect of L-DOPA on rotenone-pretreated DA neurons was significantly blocked by antioxidants, but not antagonists of NMDA or non-NMDA glutamate receptors. This indicates that oxidative stress play a central role in mediating the selective damage ...Continue Reading

References

Sep 1, 1992·Annals of Neurology·T M DawsonS H Snyder
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·M A MenaJ García de Yébenes
Jan 3, 1991·European Journal of Pharmacology·R J BridgesC W Cotman
Mar 1, 1990·Journal of Neurochemistry·A H SchapiraC D Marsden
Nov 1, 1990·Experimental Neurology·K Steece-CollierJ R Sladek
Sep 29, 1989·Biochemical and Biophysical Research Communications·Y MizunoY Kagawa
Feb 1, 1989·Journal of Neurochemistry·P RiedererM B Youdim
Sep 1, 1988·Neurology·J BlinY Agid
Jan 1, 1986·Movement Disorders : Official Journal of the Movement Disorder Society·N QuinnC D Marsden
Nov 1, 1980·The Biochemical Journal·J F Turrens, A Boveris
Dec 13, 1982·Neuroscience Letters·T L PerryS Hansen
Nov 1, 1993·Trends in Neurosciences·C W Olanow
May 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·S PrzedborskiS Fahn
Aug 5, 1993·Nature·M Lafon-CazalJ Bockaert
Jun 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·C D Marsden
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·N NakaoP Brundin
Feb 1, 1995·Journal of Neurochemistry·A N BasmaH M Geller
Oct 29, 1993·Science·J T Coyle, P Puttfarcken
Apr 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·S B BluntC D Marsden
Jul 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·B PardoJ García de Yébenes
Oct 1, 1993·Journal of Neurochemistry·C MytilineouG Cohen

❮ Previous
Next ❯

Citations

Aug 12, 2014·Molecular Neurobiology·Wooyoung JangSeong-Ho Koh
Jan 28, 2005·Neurochemical Research·Wei-Guo LiuSheng-Di Chen
Oct 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·William DauerRene Hen
Apr 23, 2009·Neurotoxicity Research·Krystyna GołembiowskaKatarzyna Kamińska
Feb 17, 2006·Journal of Medicinal Chemistry·Antonio Di StefanoFrancesco Pinnen
Aug 23, 2001·Brain Research. Brain Research Reviews·C DavidsonE H Ellinwood
Jun 6, 2000·Trends in Neurosciences·R J Jakel, W F Maragos
May 27, 2008·Brain Research Bulletin·K PrabhakaranP G Gunasekar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.